ACRO BIOMEDICAL CO., LTD.
3F, No.57, Luke 2nd Rd., Lujhu Dist, Kaohsiung City 82151, Taiwan
About us
Our Mission
ACRO Biomedical thrives to improve the health benefit of patients by providing with the unmet clinical need. We employ the most advanced technology in the biomedical field to ensure the utmost safety and efficacy of our medical products.
Company Profile
ACRO Biomedical was founded in June 2014 and positioned to develop and produce biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat, and non-collagenous proteins from animal tissues and organs, while leaving the intact collagen scaffolds as the biomaterial for high-end medical devices in the field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular, and neural surgery, etc.
Besides from the development of natural biomaterial scaffolds for tissue engineering, ACRO Biomedical has advanced in combining these tissue scaffolds with stem cells and/or somatic cells for human cell therapy in the field of skin regeneration and knee joint cartilage regeneration.
The ultimate goal for ACRO Biomedical is whole organ engineering for heart, liver, and kidney transplantation. We wish to recellularize the organ scaffold in vivo for autologous organ transplantation by grafting the decellularized natural organ scaffolds back into the live animal or human body.
Our Mission
ACRO Biomedical thrives to improve the health benefit of patients by providing with the unmet clinical need. We employ the most advanced technology in the biomedical field to ensure the utmost safety and efficacy of our medical products.
Company Profile
ACRO Biomedical was founded in June 2014 and positioned to develop and produce biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat, and non-collagenous proteins from animal tissues and organs, while leaving the intact collagen scaffolds as the biomaterial for high-end medical devices in the field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular, and neural surgery, etc.
Besides from the development of natural biomaterial scaffolds for tissue engineering, ACRO Biomedical has advanced in combining these tissue scaffolds with stem cells and/or somatic cells for human cell therapy in the field of skin regeneration and knee joint cartilage regeneration.
The ultimate goal for ACRO Biomedical is whole organ engineering for heart, liver, and kidney transplantation. We wish to recellularize the organ scaffold in vivo for autologous organ transplantation by grafting the decellularized natural organ scaffolds back into the live animal or human body.
Products
ABCcolla® Collagen Matrix
ABCcolla® Collagen Matrix is prepared by supercritical CO₂ extraction technology. It is a decellularized native porcine collagen scaffold dressing that can be used for various soft tissue reconstruction needs in dental surgery and can quickly repair missing soft tissue. The porous collagen bio-material absorbs a high level of wound exudates and maintains an optimal moist environment conducive to healing. The high degree of triple-helix nativity makes the dressing last longer in the wound. The 3D structure acts as an ECM-like scaffold, encouraging cell proliferation and migration, the formation of granulation tissue, and epithelialization to support the regeneration of the human dermis and epidermis. It is completely bioabsorbable, so it does not need to be removed from the wound site.
ABCcolla® Collagen Membrane
ABCcolla® Collagen Membrane is a decellularized porcine dermal sheet prepared by supercritical CO₂ extraction technology, which retains the native 3D scaffold structure of collagen with good mechanical strength that can withstand sutures during dental operations. It is bioabsorbable, biocompatible, non-toxic, non-irritating, and non-antigenic. It can be used as surgical wound covering in dental operations and functions as a barrier between soft and hard tissue. In addition, it provides space for efficient osteogenesis in the alveolar bone.
ABCcolla® Bone Graft
ABCcolla® Collagen Bone Graft is a decellularized native porcine bone graft material prepared by supercritical CO2 extraction technology, which is composed of native porcine collagen and bone matrix that are comparable to the human bone matrix. ABCcolla® Collagen Bone Graft is indicated to be filled into bony voids or gaps and augment oral, dental intraosseous, and craniofacial defects. These defects may include periodontal/infra-bony defects, alveolar ridge augmentation (sinusotomy, osteotomy, cystectomy), dental extraction sites (ridge maintenance, implant preparation/placement), sinus lifts, cystic defects, and craniofacial augmentation. ABCcolla® Collagen Bone Graft may be used alone in a manner comparable to autogenous bone graft chips or allograft bone particulate (demineralized freeze-dried bone), or it may be mixed with either as a bone graft extender.
ABCcolla® Bone Matrix
ABCcolla® Bone Matrix is intended for filling and augmentation of bone voids or gaps. It facilitates cell attachment and improves bone regeneration and neovascularization. During the healing process, ABCcolla® Bone Matrix is gradually resorbed and is replenished by new bone. It comes in different forms – granules, strip, wedge, cone, and cube.
ABCcolla® EZ Collagen Bone Graft
ABCcolla® EZ Collagen Bone Graft is made of type I collagen and hydroxyapatite, which is comparable to human bone. Its interconnecting macro- and micropores structure enhances cell attachment and neovascularization that accelerates bone regeneration.
ABCcolla® EZ Collagen Bone Graft is suitable for bone void filling and augmentation in bone implantation related surgeries. It can be made into desired size and shape by rehydrating with saline or patient's blood.